Caxton Associates (New York)’s Sempra SRE Stock Holding History

Caxton Associates (New York)’s Portfolio SRE Stock Details SRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,643	Closed	-$201K	–	644
2024 Q2	$201K	Buy	+2,643	New	+$195K	0.01%	445

Other funds holding SRE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Caxton Associates (New York)'s SRE Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Sempra (SRE) in Q3 2024, closing a stake of 2,643 shares — an estimated $201K sold.

Caxton Associates (New York) first reported a position in SRE in Q2 2024 and held it in 1 quarter. The position peaked at $201K in Q2 2024. 1,102 funds tracked by Wall St. Rank hold SRE as of Q3 2024.

Caxton Associates (New York) reported no remaining Sempra position as of Q3 2024 after selling out during the quarter.
Caxton Associates (New York) sold 2,643 Sempra shares in Q3 2024, an estimated $201K.
Caxton Associates (New York) first reported a position in Sempra in Q2 2024 and held it in 1 quarter.
Caxton Associates (New York)'s Sempra position peaked at $201K in Q2 2024.
1,102 funds tracked by Wall St. Rank held Sempra as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.